Atrium Therapeutics, Inc. (RNA)

Typically moves ±2.38% on earnings
EARNINGS ANALYTICS
search

Atrium Therapeutics, Inc. (RNA) has only 2 recorded earnings events on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was +4.3% (Aug 13, 2026) and its biggest decline was -0.45% (May 14, 2026).

Earnings reactions

How RNA moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

2

Avg Abs. Movement

±2.38%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 13, 2026 ☽ POST +4.3% open_in_new
May 14, 2026 ☽ POST -0.45% open_in_new
event

Earnings Count

2

Total earnings in dataset

trending_up

Avg Abs. Movement

±2.38%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 19 →
19
Funds holding
$37228142
Total value held
Buying
11 added · 8 reduced
Blackrock, Inc.
$19468551 +20.09%
Goldman Sachs Group Inc
$4174086 -11.32%
State Street Corp
$3655199 +5.71%
Janus Henderson Group Plc
$1871370 NEW BUY
Nomura Holdings Inc
$1847949 +0.01%

Frequently asked about RNA earnings

How much does RNA stock move after earnings? expand_more

Over 2 reports, RNA has moved an average of ±2.38% the session after earnings, closing higher 50.0% of the time.

What was RNA's biggest post-earnings move? expand_more

RNA's largest post-earnings gain on record was +4.3% on Aug 13, 2026, and its largest decline was -0.45% on May 14, 2026.

Where can I find Atrium Therapeutics, Inc.'s SEC filings? expand_more

All of Atrium Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.